These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7968513)

  • 1. Proteolytic cleavage at arginine residues within the hydrophilic disulphide loop of the Escherichia coli Shiga-like toxin I A subunit is not essential for cytotoxicity.
    Burgess BJ; Roberts LM
    Mol Microbiol; 1993 Oct; 10(1):171-9. PubMed ID: 7968513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.
    Perera LP; Samuel JE; Holmes RK; O'Brien AD
    J Bacteriol; 1991 Feb; 173(3):1151-60. PubMed ID: 1991714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolytic cleavage of the A subunit is essential for maximal cytotoxicity of Escherichia coli O157:H7 Shiga-like toxin-1.
    Lea N; Lord JM; Roberts LM
    Microbiology (Reading); 1999 May; 145 ( Pt 5)():999-1004. PubMed ID: 10376814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RNA-N-glycosidase activity of Shiga-like toxin I: kinetic parameters of the native and activated toxin.
    Brigotti M; Carnicelli D; Alvergna P; Mazzaracchio R; Sperti S; Montanaro L
    Toxicon; 1997 Sep; 35(9):1431-7. PubMed ID: 9403966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that proteolytic separation of Shiga-like toxin type IIv A subunit into A1 and A2 subunits is not required for toxin activity.
    Samuel JE; Gordon VM
    J Biol Chem; 1994 Feb; 269(7):4853-9. PubMed ID: 7906271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vero toxins (Shiga-like toxins) produced by enterohemorrhagic Escherichia coli (verocytotoxin-producing E. coli).
    Takeda Y; Kurazono H; Yamasaki S
    Microbiol Immunol; 1993; 37(8):591-9. PubMed ID: 8246822
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants.
    Garred O; Dubinina E; Holm PK; Olsnes S; van Deurs B; Kozlov JV; Sandvig K
    Exp Cell Res; 1995 May; 218(1):39-49. PubMed ID: 7737376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.
    Endo Y; Tsurugi K; Yutsudo T; Takeda Y; Ogasawara T; Igarashi K
    Eur J Biochem; 1988 Jan; 171(1-2):45-50. PubMed ID: 3276522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of arginine at position 170 of the A subunit of Vero toxin 1 produced by enterohemorrhagic Escherichia coli for toxin activity.
    Yamasaki S; Furutani M; Ito K; Igarashi K; Nishibuchi M; Takeda Y
    Microb Pathog; 1991 Jul; 11(1):1-9. PubMed ID: 1795624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of an internal membrane-spanning region in Shiga toxin 1 reduces cytotoxicity.
    Suhan ML; Hovde CJ
    Infect Immun; 1998 Nov; 66(11):5252-9. PubMed ID: 9784530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis.
    Jackson MP; Wadolkowski EA; Weinstein DL; Holmes RK; O'Brien AD
    J Bacteriol; 1990 Feb; 172(2):653-8. PubMed ID: 2404947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical and biological properties of purified Escherichia coli Shiga-like toxin II variant.
    MacLeod DL; Gyles CL; Valdivieso-Garcia A; Clarke RC
    Infect Immun; 1991 Apr; 59(4):1300-6. PubMed ID: 2004812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Furin-induced cleavage and activation of Shiga toxin.
    Garred O; van Deurs B; Sandvig K
    J Biol Chem; 1995 May; 270(18):10817-21. PubMed ID: 7738018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escherichia coli cytotoxins and enterotoxins.
    Gyles CL
    Can J Microbiol; 1992 Jul; 38(7):734-46. PubMed ID: 1393838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of ribosome binding by the Shiga toxin A1 subunit, using competition and site-directed mutagenesis.
    Skinner LM; Jackson MP
    J Bacteriol; 1997 Feb; 179(4):1368-74. PubMed ID: 9023224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.
    Weinstein DL; Jackson MP; Samuel JE; Holmes RK; O'Brien AD
    J Bacteriol; 1988 Sep; 170(9):4223-30. PubMed ID: 3045088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas exotoxin exhibits increased sensitivity to furin when sequences at the cleavage site are mutated to resemble the arginine-rich loop of diphtheria toxin.
    Chiron MF; Ogata M; FitzGerald DJ
    Mol Microbiol; 1996 Nov; 22(4):769-78. PubMed ID: 8951823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of recombinant shiga-like toxin type I B subunit.
    Austin PR; Hovde CJ
    Protein Expr Purif; 1995 Dec; 6(6):771-9. PubMed ID: 8746629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for the protease-sensitive loop region of Shiga-like toxin 1 in the retrotranslocation of its A1 domain from the endoplasmic reticulum lumen.
    LaPointe P; Wei X; Gariépy J
    J Biol Chem; 2005 Jun; 280(24):23310-8. PubMed ID: 15817449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit.
    Bast DJ; Banerjee L; Clark C; Read RJ; Brunton JL
    Mol Microbiol; 1999 Jun; 32(5):953-60. PubMed ID: 10361298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.